ArticleBMC gastroenterology2026
Clinical and biochemical factors associated with moderate-to-severe ulcerative colitis: a retrospective case-control study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort".Journal of gastroenterology and hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundTo explore the influencing factors of ulcerative colitis (UC) in patients and provide a scientific basis for the prevention and control of UC.
methodsA retrospective selection of 241 patients diagnosed with ulcerative colitis from January 2020 to December 2024 at the People's Hospital of Xinjiang Uygur Autonomous Region was conducted according to the inclusion criteria. Patients were divided into two groups based on the severity of UC during the active phase: control group (n = 132) and experimental group (n = 109). Univariate analysis of basic patient information was performed, and variables with P < 0.05 were further analyzed using a binary logistic regression model to explore the association with moderate-to-severe UC.
resultsIn this study involving 241 patients, data from the experimental group (109 cases, age 46.80 ± 13.80) were compared with the control group (132 cases, age 47.71 ± 13.90). Univariate analysis showed that variables such as corticosteroid use, history of hypertension, history of anemia, leukocyte count, red blood cell count, platelet count, neutrophils, lymphocytes, C-reactive protein, erythrocyte sedimentation rate (ESR), total protein, albumin, globulin, albumin/globulin ratio, and direct bilirubin were statistically significant (P < 0.05). Binary logistic regression analysis showed that hypertension (95% CI: 0.053–0.491, P = 0.001), lymphocytes (95% CI: 0.285–0.998, P = 0.049), ESR (95% CI: 1.006–1.060, P = 0.017), and direct bilirubin (95% CI: 0.735–0.988, P = 0.034) were all associated with moderate-to-severe UC. ESR and hypertension were identified as risk factors for moderate-to-severe UC, while lymphocytes and direct bilirubin were protective factors.
conclusionsThis retrospective study indicates that hypertension, lymphocytes, ESR, and direct bilirubin are associated with moderate-to-severe UC. Therefore, markers such as ESR, hypertension, lymphocytes, and direct bilirubin can enhance the efficiency of diagnosing moderate-to-severe UC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.